PALU', GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 56.705
EU - Europa 6.473
AS - Asia 6.377
SA - Sud America 39
OC - Oceania 33
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 13
Totale 69.662
Nazione #
US - Stati Uniti d'America 56.633
CN - Cina 3.526
SG - Singapore 2.200
IT - Italia 1.778
FI - Finlandia 1.284
DE - Germania 972
SE - Svezia 681
UA - Ucraina 531
FR - Francia 486
GB - Regno Unito 410
VN - Vietnam 394
IE - Irlanda 108
IN - India 95
HK - Hong Kong 67
NL - Olanda 65
CA - Canada 47
RU - Federazione Russa 36
TR - Turchia 22
AU - Australia 21
JP - Giappone 20
BZ - Belize 19
BR - Brasile 15
IR - Iran 13
PL - Polonia 13
PT - Portogallo 13
SI - Slovenia 13
EU - Europa 12
NZ - Nuova Zelanda 12
BE - Belgio 10
RO - Romania 10
AR - Argentina 9
BG - Bulgaria 7
CZ - Repubblica Ceca 7
ID - Indonesia 7
KR - Corea 7
CH - Svizzera 6
HU - Ungheria 6
ZA - Sudafrica 6
ES - Italia 5
GR - Grecia 5
LU - Lussemburgo 5
CO - Colombia 4
HR - Croazia 4
KH - Cambogia 4
MX - Messico 4
PH - Filippine 4
AL - Albania 3
AT - Austria 3
CL - Cile 3
EC - Ecuador 3
MD - Moldavia 3
NG - Nigeria 3
TW - Taiwan 3
BO - Bolivia 2
CM - Camerun 2
DK - Danimarca 2
IL - Israele 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
IM - Isola di Man 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MG - Madagascar 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
RS - Serbia 1
SD - Sudan 1
SV - El Salvador 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 69.662
Città #
Fairfield 8.342
Woodbridge 6.261
Houston 5.178
Ann Arbor 4.493
Chandler 4.226
Ashburn 3.701
Wilmington 3.145
Seattle 2.984
Cambridge 2.966
Jacksonville 2.703
Singapore 1.773
Boardman 1.320
Princeton 1.246
Santa Clara 1.157
Beijing 855
San Diego 829
Des Moines 632
Roxbury 614
Medford 604
Nanjing 529
Helsinki 497
Padova 490
Dong Ket 390
Guangzhou 230
Shenyang 193
Nanchang 180
Hebei 159
Norwalk 124
New York 123
Jiaxing 115
Tianjin 98
Jinan 95
Dublin 94
London 93
Changsha 92
Redwood City 82
Falls Church 81
Milan 73
Shanghai 63
Hefei 56
Hong Kong 54
Rome 54
Washington 51
Ogden 47
Dearborn 46
Aprilia 43
Frankfurt am Main 37
Zhengzhou 37
Kilburn 36
Kharkiv 35
Tappahannock 35
Indiana 34
Kunming 33
Borås 30
Columbus 30
Dallas 30
Los Angeles 28
Chicago 27
Munich 27
Phoenix 27
Ningbo 23
Pune 23
San Jose 23
Taizhou 23
Haikou 22
Hangzhou 22
Las Vegas 21
Belize City 19
Vicenza 19
Taiyuan 18
Berlin 17
Nürnberg 17
Hounslow 16
Paris 16
Venice 16
Detroit 15
Fuzhou 15
Genoa 15
Rockville 15
Toronto 15
Buffalo 14
Lanzhou 14
Catania 13
Florence 13
Orange 13
Treviso 13
Amsterdam 12
Camponogara 12
Portland 12
Chiswick 11
Turin 11
Wuhan 11
Groningen 10
Menlo Park 10
Redmond 10
Yenibosna 10
Auburn Hills 9
Bologna 9
Falkenstein 9
Prescot 9
Totale 58.222
Nome #
Personalized stem cell therapy to correct corneal defects due to a unique homozygous-heterozygous mosaicism of ectrodactyly-ectodermal dysplasia-clefting syndrome 206
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 201
Derivati dell'aloe-emodina e loro impiego nel trattamento di patologie neoplastiche 189
Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma 178
Viral infections of the central nervous system in elderly patients: A retrospective study 177
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process 172
Lactobacillus crispatus M247-Derived H2O2 Acts as a Signal Transducing Molecule Activating Peroxisome Proliferator Activated Receptor-γ in the Intestinal Mucosa 171
Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy. 169
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 169
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 166
Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection 162
Antiviral strategies against influenza virus: towards new therapeutic approaches. 161
Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation 160
Nucleolin stabilizes G-quadruplex structures folded by the LTR promoter and silences HIV-1 viral transcription 160
Changes in microRNA expression during disease progression in patients with chronic viral hepatitis 159
Clostridium difficile TxA(C314) and SLP-36kDa enhance the immune response toward a co-administered antigen 158
A Sterilization Method for Decellularized Xenogeneic Cardiovascular Scaffolds 157
Strategies and methods in monitoring and targeting protein-protein interactions. 156
New Frontiers of Corneal Gene Therapy 155
Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: Complexity and vaccine implications 155
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction 154
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men 153
Drug Repurposing for Viral Infectious Diseases: How Far Are We? 153
Mapping and characterization of G-quadruplexes in Mycobacterium tuberculosis gene promoter regions 151
Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain 150
Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs 149
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 149
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment 149
Alcohol Dependence and Criminal Behavior: Preliminary Results of an Association Study of Environmental and Genetic Factors in an Italian Male Population 147
Promoter mutagenesis for fine-tuning expression of essential genes in Mycobacterium tuberculosis 147
A Prospective Study on the Predictive Value of Plasma BK Virus-DNA Load for Hemorrhagic Cystitis in Pediatric Patients After Stem Cell Transplantation 147
Human papillomavirus sperm infection and assisted reproduction: a dangerous hazard with a possible safe solution. 146
Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells. 146
A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation 145
Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. 145
Relevance of DNA binding to the mechanism of anti-herpesvirus activity of benzhydrazone 145
Development of retroviral vectors for combined suicide and immunomodulating gene therapy of hepatocellular carcinoma (HCC) 143
Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014 143
Substituted quinazolinones as kinase inhibitors endowed with anti-fibrotic properties 143
Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach 142
Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma - Characterization of the dysfunctional protein C Padua(3) (Protein CR-1L/propeptide) 140
Torque Teno Virus: any pathological role in liver transplanted patients? 140
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives. 139
T cell engineering by a chimeric T cell receptor with antibody-type specificity for the HIV-1 gp120 139
Additive and antagonist effects of therapeutic gene combinations for suppression of HIV-1 infection 139
Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection 139
Human papillomavirus infection is not involved in esophageal verrucous carcinoma 138
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 138
vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity 137
Adenoviral Vector-Mediated Gene Therapy for Adenocortical Carcinoma: Therapeutic Strategies and Safety Considerations 137
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity 137
The cellular protein hnRNP A2/B1 enhances HIV-1 transcription by unfolding LTR promoter G-quadruplexes 137
Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype 136
Characterization of Intra-Type Variants of Oncogenic Human Papillomaviruses by Next-Generation Deep Sequencing of the E6/E7 Region 136
4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy 136
A Dynamic G-Quadruplex Region Regulates the HIV-1 Long Terminal Repeat Promoter 135
MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis 135
Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detection 134
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 134
Generation of a transgene-free human induced pluripotent stem cell line (UNIPDi001-A) from oral mucosa epithelial stem cells 134
Comparison of CMV ELISPOT and CMV Quantiferon™ interferon-γ releasing assays in assessing risk of CMV infection in kidney transplant recipients. 133
Optimization of Interferon gamma ELISPOT assay to detect Human Cytomegalovirus specific T-cell responses in solid organ transplants 133
Detection of WU Polyomavirus in Cerebrospinal Fluid Specimen from a Patient with AIDS and Suspected Progressive Multifocal Leukoencephalopathy 132
Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest Virus 132
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma 132
Ebola Virus Entry: From Molecular Characterization to Drug Discovery 132
Collaborative national multicenter for the identification of conversion factors from copies/mL to international units/mL for the normalization of HCMV DNA load 132
Cytomegalovirus (CMV) enzyme-linked immunosorbent spot assay but not cmv quantiferon assay is a novel biomarker to determine risk of congenital cmv infection in pregnant women 130
Correction of Mutant p63 in EEC Syndrome Using siRNA Mediated Allele-Specific Silencing Restores Defective Stem Cell Function 130
Large Human Outbreak of West Nile Virus Infection in North-Eastern Italy in 2012 129
Full genome sequence-based comparative study of wild-type and vaccine strains of infectious laryngotracheitis virus from Italy 129
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 129
Analysis of topoisomerase (TOP) expression in peripheral blood mononuclear cell (PBMCs) from patients (PTS) undergoing chemotherapy (CHT) for solid tumors(ST) 129
HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys 128
Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment. 127
Phylogenetic characterization of Central/Southern European lineage 2 West Nile virus: Analysis of human outbreaks in Italy and Greece, 2013-2014 127
Visualization of DNA G-quadruplexes in herpes simplex virus 1-infected cells 127
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 127
Improving the stability of the TetR/Pip-OFF mycobacterial repressible promoter system 127
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 127
Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli 126
Kinetics of Linezolid in Continuous Renal Replacement Therapy: An in Vitro Study 126
Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression 126
Identification and Characterization of an Extracellular Protease Activity Produced by the Marine Vibrio sp. 60. 126
Clustering and Risk Factors of Methicillin-Resistant Staphylococcus aureus Carriage in Two Italian Long-Term Care Facilities 125
Inhibition of ShcA isoforms p46/p52Shc enhances HIV-1 replication in CD4+ T-lymphocytes 125
Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases 125
Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors 125
Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women 125
Report of two cases of Influenza virus A/H1N1v and B co-infection during the 2010/2011 epidemics in the Italian Veneto Region 125
6-aminoquinolones as new potential anti-HIV agents 124
Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated with Increased Risk of Fetal Infection in Primarily Infected Pregnant Women 124
Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors 124
Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems 124
Assessing the role of Rv1222 (RseA) as an anti-sigma factor of the Mycobacterium tuberculosis extracytoplasmic sigma factor SigE 124
Autocrine-paracrine role of endothelin-1 in the regulation of aldosterone synthase expression and intracellular Ca2+ in human adrenocortical carcinoma NCI-H295 cells. 124
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly. 123
Toll like receptor-2 regulates production of glial-derived neurotrophic factors in murine intestinal smooth muscle cells 123
Herpes Simplex Virus Type 1 infects enteric neurons and triggers gut dysfunction via macrophage recruitment. 123
Synthesis of pyrrolo[3,2-h]quinolinones with good photochemotherapeutic activity and no DNA damage 122
Totale 14.149
Categoria #
all - tutte 242.159
article - articoli 203.781
book - libri 103
conference - conferenze 0
curatela - curatele 0
other - altro 403
patent - brevetti 1.007
selected - selezionate 0
volume - volumi 2.028
Totale 449.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.616 0 0 0 0 0 1.070 1.349 1.565 1.645 1.508 866 613
2020/20219.471 458 710 409 790 465 765 318 919 1.460 1.024 1.245 908
2021/202210.874 259 1.556 1.356 709 489 540 559 1.129 481 210 1.132 2.454
2022/20238.926 1.722 938 193 1.043 1.453 1.282 38 595 1.062 84 397 119
2023/20244.239 208 655 576 359 330 391 322 216 104 165 433 480
2024/20255.624 72 1.270 726 632 2.604 320 0 0 0 0 0 0
Totale 70.490